Name: UMIN ID:
Unique ID issued by UMIN | UMIN000013031 |
---|---|
Receipt number | R000015209 |
Scientific Title | Neoadjuvant S-1 therapy for resectable pancreatic cancer patients; A phase2 study |
Date of disclosure of the study information | 2014/01/31 |
Last modified on | 2022/09/27 09:41:14 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/01/31 13:22:49 | ||
2 | Update | 2016/08/16 10:43:13 | Recruitment status |
|
3 | Update | 2019/03/18 10:03:31 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Name of primary person or sponsor Organization Organization Organization Address Address Tel |
|
4 | Update | 2019/03/18 10:05:34 | Number of participants that the trial has enrolled |
|
5 | Update | 2019/03/18 10:48:01 | Recruitment status Date of IRB Last follow-up date |
|
6 | Update | 2019/03/18 12:17:52 | URL releasing protocol URL related to results and publications Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
7 | Update | 2022/09/27 09:41:14 | Publication of results URL related to results and publications |